floxacillin has been researched along with linezolid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Balan, D; Li, Z; Nathwani, D; Rittenhouse, B; Vinken, A; Wilike, R | 1 |
| Dady, I; Khattak, SG; Mukherjee, D | 1 |
| Alav, I; Allen, F; Harrington, NE; Harrison, F; Moat, J; Sweeney, E | 1 |
| Falla, E; Mantopoulos, T; Nathwani, D; Vlachaki, I; Zinzi, D | 1 |
9 other study(ies) available for floxacillin and linezolid
| Article | Year |
|---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Utilization Review; Floxacillin; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Public; Humans; Infection Control; Infusions, Intravenous; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United Kingdom; Vancomycin | 2001 |
Unusual presentation of late-onset disseminated staphylococcal sepsis in a preterm infant.
Topics: Anti-Bacterial Agents; Floxacillin; Humans; Infant, Newborn; Infant, Premature; Linezolid; Magnetic Resonance Imaging; Male; Neonatal Sepsis; Staphylococcal Infections; Staphylococcus aureus; Whole Body Imaging | 2019 |
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Colistin; Colony Count, Microbial; Cystic Fibrosis; Dissection; Floxacillin; Humans; Linezolid; Lung; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Sputum; Staphylococcus aureus; Swine | 2021 |
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective.
Topics: Anti-Bacterial Agents; Daptomycin; Floxacillin; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Quality of Life; State Medicine; Teicoplanin; Vancomycin | 2022 |